175 related articles for article (PubMed ID: 28823868)
1. The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
Leite Dantas R; Brachvogel B; Schied T; Bergmeier V; Skryabin B; Vogl T; Ludwig S; Wixler V
Am J Pathol; 2017 Nov; 187(11):2388-2398. PubMed ID: 28823868
[TBL] [Abstract][Full Text] [Related]
2. The Four-and-a-Half LIM Domain Protein 2 Supports Influenza A Virus-Induced Lung Inflammation by Restricting the Host Adaptive Immune Response.
Masemann D; Leite Dantas R; Sitnik S; Schied T; Nordhoff C; Ludwig S; Wixler V
Am J Pathol; 2018 May; 188(5):1236-1245. PubMed ID: 29458009
[TBL] [Abstract][Full Text] [Related]
3. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
4. LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway.
van de Pol V; Vos M; DeRuiter MC; Goumans MJ; de Vries CJM; Kurakula K
Vascul Pharmacol; 2020; 125-126():106634. PubMed ID: 31866461
[TBL] [Abstract][Full Text] [Related]
5. FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis.
Wixler V; Cromme C; Retser E; Meyer LH; Smyth N; Mühlenberg K; Korb-Pap A; Koers-Wunrau C; Sotsios Y; Bassel-Duby R; Baeten D; Tak PP; Niederreiter B; Redlich K; Bertrand J; Skryabin BV; Ludwig S; Pap T
Ann Rheum Dis; 2015 Dec; 74(12):2216-23. PubMed ID: 25125695
[TBL] [Abstract][Full Text] [Related]
6. The roles of FHL2 in cancer.
Zhang J; Zeng Q; She M
Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
[TBL] [Abstract][Full Text] [Related]
7. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
[TBL] [Abstract][Full Text] [Related]
9. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
[TBL] [Abstract][Full Text] [Related]
10. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
11. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
12. FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity.
Canault M; Tellier E; Bonardo B; Mas E; Aumailley M; Juhan-Vague I; Nalbone G; Peiretti F
J Cell Physiol; 2006 Aug; 208(2):363-72. PubMed ID: 16619241
[TBL] [Abstract][Full Text] [Related]
13. Four and a half LIM domain protein 2 enhances differentiation and mineralization of human dental pulp cells.
Tian X; Wang Q; Wang X
J Endod; 2015 Apr; 41(4):513-9. PubMed ID: 25662359
[TBL] [Abstract][Full Text] [Related]
14. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of FHL2 attenuates airway inflammation in mice and genetic variation associates with human bronchial hyper-responsiveness.
Kurakula K; Vos M; Logiantara A; Roelofs JJ; Nieuwenhuis MA; Koppelman GH; Postma DS; Brandsma CA; Sin DD; Bossé Y; Nickle DC; van Rijt LS; de Vries CJ
Allergy; 2015 Dec; 70(12):1531-44. PubMed ID: 26222912
[TBL] [Abstract][Full Text] [Related]
16. Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity.
Clemente-Olivo MP; Habibe JJ; Vos M; Ottenhoff R; Jongejan A; Herrema H; Zelcer N; Kooijman S; Rensen PCN; van Raalte DH; Nieuwdorp M; Eringa EC; de Vries CJ
Metabolism; 2021 Aug; 121():154815. PubMed ID: 34119536
[TBL] [Abstract][Full Text] [Related]
17. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
18. FHL2 Is Essential for Spleen T Cell-Dependent B Cell Activation and Antibody Response.
Ebrahimian T; Dierick F; Simon D; Heidari M; Orthwein A; Mann KK; Lehoux S
Immunohorizons; 2020 May; 4(5):259-273. PubMed ID: 32434880
[TBL] [Abstract][Full Text] [Related]
19. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
20. The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosis.
Alnajar A; Nordhoff C; Schied T; Chiquet-Ehrismann R; Loser K; Vogl T; Ludwig S; Wixler V
PLoS One; 2013; 8(11):e81356. PubMed ID: 24260575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
